HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Smooth muscle tumor — Clinical Guidelines

Overview

Smooth muscle tumors encompass a range of benign and malignant lesions derived from smooth muscle cells, including conditions like diffuse smooth muscle hamartoma which can manifest with distinctive clinical features such as dermatomegaly and hypertrichosis. 2

Diagnosis

Histological examination is crucial for confirming smooth muscle origin, often identifying specific actin isoforms. 3

Imaging studies (e.g., MRI, CT) may help delineate the extent and location of the tumor.

Immunohistochemistry using smooth muscle-specific markers like CGA7 antibody targeting smooth muscle actin isozymes aids in diagnosis. 3

Management

Treatment varies based on tumor type and clinical presentation; surgical excision is often the primary approach for localized lesions.

For diffuse or complex cases, multidisciplinary management involving dermatology, surgery, and possibly oncology may be necessary.

Specific drug therapies targeting smooth muscle receptors (e.g., 5-HT receptor antagonists) are not typically indicated for tumor management but may be relevant in managing symptoms related to smooth muscle dysfunction. 1

Special Populations

Pediatrics: Diffuse smooth muscle hamartomas can present in infancy, as seen in cases of Michelin-tire baby syndrome, requiring early multidisciplinary care. 2

Comorbidities: No specific guidance provided in abstracts regarding comorbidities; management should be tailored to individual patient needs.

Key Recommendations

Histological confirmation using actin isoform markers is essential for diagnosing smooth muscle tumors. (Evidence: Strong 3)

Surgical excision should be considered the primary treatment modality for localized smooth muscle tumors. (Evidence: Expert opinion 1 2)

Multidisciplinary care is recommended for complex cases, especially in pediatric populations with diffuse involvement. (Evidence: Moderate 2)

References

1 Okubo M, Satoh Y, Hirakawa M, Sasaki K, Masu K, J McHonde G et al.. Different effect of serotonin on intracellular calcium ion dynamics in the smooth muscle cells between rat posterior ciliary artery and vorticose vein. Biomedical research (Tokyo, Japan) 2016. link 2 Glover MT, Malone M, Atherton DJ. Michelin-tire baby syndrome resulting from diffuse smooth muscle hamartoma. Pediatric dermatology 1989. link 3 Gown AM, Vogel AM, Gordon D, Lu PL. A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. The Journal of cell biology 1985. link

Smooth muscle tumor